PL358255A1 - Water-soluble powders for oral solution and use thereof - Google Patents

Water-soluble powders for oral solution and use thereof

Info

Publication number
PL358255A1
PL358255A1 PL00358255A PL35825500A PL358255A1 PL 358255 A1 PL358255 A1 PL 358255A1 PL 00358255 A PL00358255 A PL 00358255A PL 35825500 A PL35825500 A PL 35825500A PL 358255 A1 PL358255 A1 PL 358255A1
Authority
PL
Poland
Prior art keywords
water
oral solution
soluble powders
powders
soluble
Prior art date
Application number
PL00358255A
Other languages
Polish (pl)
Inventor
Vesna Skulj
Vipotnik Alenka Mihelic
Original Assignee
Lek Farmacevtska Druzba D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Farmacevtska Druzba D.D. filed Critical Lek Farmacevtska Druzba D.D.
Publication of PL358255A1 publication Critical patent/PL358255A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL00358255A 1999-12-22 2000-12-19 Water-soluble powders for oral solution and use thereof PL358255A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9900283A SI20411A (en) 1999-12-22 1999-12-22 Watersoluble powders for peroral solution and their use
PCT/SI2000/000028 WO2001045667A2 (en) 1999-12-22 2000-12-19 Water-soluble powders for oral solution and use thereof

Publications (1)

Publication Number Publication Date
PL358255A1 true PL358255A1 (en) 2004-08-09

Family

ID=20432571

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00358255A PL358255A1 (en) 1999-12-22 2000-12-19 Water-soluble powders for oral solution and use thereof

Country Status (4)

Country Link
AU (1) AU1912501A (en)
PL (1) PL358255A1 (en)
SI (1) SI20411A (en)
WO (1) WO2001045667A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
WO2014062568A2 (en) * 2012-10-15 2014-04-24 Pathway Pharma, Llc Amoxicillin formulation and method of using such formulation
CN104983685A (en) * 2015-06-25 2015-10-21 四川恒通动物制药有限公司 Amoxicillin soluble powder and preparation method
CN105168145A (en) * 2015-10-29 2015-12-23 林州中农生物肽科技有限公司 Compound amoxycillin soluble powder and preparation method thereof
CN105287389A (en) * 2015-10-29 2016-02-03 林州中农生物肽科技有限公司 Amoxicillin soluble powder and preparation method thereof
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
CN110522730B (en) * 2019-07-31 2021-10-01 洛阳惠中兽药有限公司 Amoxicillin soluble powder and preparation method thereof
CN114886893B (en) * 2021-07-30 2023-09-29 江苏恒丰强生物技术有限公司 Compound amoxicillin powder and preparation method thereof
CN114869884A (en) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 Compound amoxicillin powder for porcine respiratory diseases and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد K-clavulanate/tri hydrate formulations
KR890701104A (en) * 1987-05-27 1989-12-19 에지.지.제이.베르미렌, 에이.디.도우마 Rapidly Soluble Anhydrous Composition of β-lactam Antibiotic
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation

Also Published As

Publication number Publication date
AU1912501A (en) 2001-07-03
WO2001045667A2 (en) 2001-06-28
WO2001045667A3 (en) 2002-05-02
SI20411A (en) 2001-06-30

Similar Documents

Publication Publication Date Title
IL133031A0 (en) Powder inhaler
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
HK1048999A1 (en) Azepinoindole derivatives, their preparation and use thereof
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
HUP0200548A2 (en) Pharmaceutical compositions and their use
HRP20060251B1 (en) Substituted oxasolidinones and their use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
PL358255A1 (en) Water-soluble powders for oral solution and use thereof
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
EG22491A (en) Rest-breaking composition and use thereof
GB9905318D0 (en) Powder analysis
GB9923045D0 (en) New oral formulations
EP1126480A4 (en) Magnet powder and method for preparation thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
HUP0202377A2 (en) N-substituted perhydrodiazines, preparation and use thereof
EP1221941A4 (en) Powder pharmaceutical formulations
IL135452A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
EP1201245A4 (en) Functional oral preparations
EP1224939A4 (en) Interferon complex and medicinal use thereof
AU2002211147A1 (en) Apparatus for making dental inlays and the like
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)